Fibroblast growth factor signaling in tumorigenesis

Ornitz, 2001, Fibroblast growth factors, Genome Biol, 2, 3005, 10.1186/gb-2001-2-3-reviews3005

McKeehan, 1998, The heparan–sulfate fibroblast growth-factor family—diversity of structure and function, Prog Nucleic Acid Res Mol Biol, 59, 135, 10.1016/S0079-6603(08)61031-4

Klint, 1999, Signal transduction by fibroblast growth factor receptors, Front Biosci, 4, 165, 10.2741/Klint

Casci, 1999, Sprouty, an intracellular inhibitor of Ras signalling, Cell, 96, 655, 10.1016/S0092-8674(00)80576-0

Hacohen, 1998, Sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways, Cell, 92, 253, 10.1016/S0092-8674(00)80919-8

Furthauer, 2002, Sef is a feedback-induced antagonist of Ras/MAPK-mediated FGF signalling, Nat Cell Biol, 4, 170, 10.1038/ncb750

Tsang, 2002, Identification of Sef, a novel modulator of FGF signalling, Nat Cell Biol, 4, 165, 10.1038/ncb749

Ciruna, 1997, Chimeric analysis of fibroblast growth-factor receptor-1 (FGFR1) function—a role for FGFR1 in morphogenetic movement through the primitive streak, Development, 124, 2829, 10.1242/dev.124.14.2829

Deng, 1994, Murine FGFR-1 is required for early postimplantation growth and axial organization, Genes Dev, 8, 3045, 10.1101/gad.8.24.3045

Ciruna, 2001, FGF signaling regulates mesoderm cell fate specification and morphogenetic movement at the primitive streak, Dev Cell, 1, 37, 10.1016/S1534-5807(01)00017-X

Yamaguchi, 1994, FGFR-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation, Genes Dev, 8, 3032, 10.1101/gad.8.24.3032

Beiman, 1996, Heartless a Drosophila FGF receptor homolog, is essential for cell migration and establishment of several mesodermal lineages, Genes Dev, 10, 2993, 10.1101/gad.10.23.2993

Gisselbrecht, 1996, Heartless encodes a fibroblast growth factor receptor (DFR1/DFGF-R2) involved in the directional migration of early mesodermal cells in the Drosophila embryo, Genes Dev, 10, 3003, 10.1101/gad.10.23.3003

De Moerlooze, 2000, An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal–epithelial signalling during mouse organogenesis, Development, 127, 483, 10.1242/dev.127.3.483

Petiot, 2003, A crucial role for Fgfr2-IIIb signalling in epidermal development and hair follicle patterning, Development, 130, 5493, 10.1242/dev.00788

Revest, 2001, Development of the thymus requires signaling through the fibroblast growth factor receptor R2-IIIb, J Immunol, 167, 1954, 10.4049/jimmunol.167.4.1954

Yu, 2003, Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth, Development, 130, 3063, 10.1242/dev.00491

Colvin, 1996, Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3, Nat Genet, 12, 390, 10.1038/ng0496-390

Werner, 1994, The function of KGF in morphogenesis of epithelium and reepithelialization of wounds, Science, 266, 819, 10.1126/science.7973639

Jameson, 2002, A role for skin gammadelta T cells in wound repair, Science, 296, 747, 10.1126/science.1069639

Werner, 1998, Keratinocyte growth factor: a unique player in epithelial repair processes, Cytokine Growth Factor Rev, 9, 153, 10.1016/S1359-6101(98)00010-0

Meropol, 2003, Randomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy: potential role as mucosal protectant, J Clin Oncol, 21, 1452, 10.1200/JCO.2003.10.079

Callahan, 2000, MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways, Oncogene, 19, 992, 10.1038/sj.onc.1203276

Katoh, 2002, WNT and FGF gene clusters (review), Int J Oncol, 21, 1269

Dickson, 2000, Tyrosine kinase signalling in breast cancer: fibroblast growth factors and their receptors, Breast Cancer Res, 2, 191, 10.1186/bcr53

Peters, 1986, Concerted activation of two potential proto-oncogenes in carcinomas induced by mouse mammary tumour virus, Nature, 320, 628, 10.1038/320628a0

van Leeuwen, 1995, Oncogene activation and oncogene cooperation in MMTV-induced mouse mammary cancer, Semin Cancer Biol, 6, 127, 10.1006/scbi.1995.0018

Shackleford, 1993, Mouse mammary-tumor virus-infection accelerates mammary carcinogenesis in wnt-1 transgenic mice by insertional activation of int-2/fgf-3 and hst/fgf-4, Proc Natl Acad Sci USA, 90, 740, 10.1073/pnas.90.2.740

Welm, 2002, Inducible dimerization of FGFR1: development of a mouse model to analyze progressive transformation of the mammary gland, J Cell Biol, 157, 703, 10.1083/jcb.200107119

Cunha, 2003, Role of the stromal microenvironment in carcinogenesis of the prostate, Int J Cancer, 107, 1, 10.1002/ijc.11335

Yan, 1993, Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy, Mol Cell Biol, 13, 4513, 10.1128/MCB.13.8.4513

Feng, 1997, Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells, Cancer Res, 57, 5369

Ornitz, 2002, FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease, Genes Dev, 16, 1446, 10.1101/gad.990702

Kandel, 1991, Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma, Cell, 66, 1095, 10.1016/0092-8674(91)90033-U

Arbeit, 1996, Upregulation of fibroblast growth factors and their receptors during multi-stage epidermal carcinogenesis in K14-HPV16 transgenic mice, Oncogene, 13, 1847

Jouanneau, 1994, A minority of carcinoma cells producing acidic fibroblast growth factor induces a community effect for tumor progression, Proc Natl Acad Sci USA, 91, 286, 10.1073/pnas.91.1.286

Jouanneau, 1997, FGF-2 and FGF-1 expressed in rat bladder carcinoma cells have similar angiogenic potential but different tumorigenic properties in vivo, Oncogene, 14, 671, 10.1038/sj.onc.1200883

Okada-Ban, 1999, Nuclear 24kD fibroblast growth factor (FGF)-2 confers metastatic properties on rat bladder carcinoma cells, Oncogene, 18, 6719, 10.1038/sj.onc.1203092

Ricol, 1999, Tumour suppressive properties of fibroblast growth factor receptor 2-IIIb in human bladder cancer, Oncogene, 18, 7234, 10.1038/sj.onc.1203186

Diez de Medina, 1997, Decreased expression of keratinocyte growth factor receptor in a subset of human transitional cell bladder carcinomas, Oncogene, 14, 323, 10.1038/sj.onc.1200830

Cappellen, 1997, Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas of the bladder, Oncogene, 14, 3059, 10.1038/sj.onc.1201154

Cappellen, 1999, Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas, Nat Genet, 23, 18, 10.1038/12615

Cross, 2002, Tyrosine kinase fusion genes in chronic myeloproliferative diseases, Leukemia, 16, 1207, 10.1038/sj.leu.2402556

Munro, 2003, Fibroblast growth factors and their receptors in transitional cell carcinoma, J Urol, 169, 675, 10.1016/S0022-5347(05)63991-2

Bakkar, 2003, FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder, Cancer Res, 63, 8108

Karoui, 2001, No evidence of somatic FGFR3 mutation in various types of carcinoma, Oncogene, 20, 5059, 10.1038/sj.onc.1204651

Jang, 2001, Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers, Cancer Res, 61, 3541

van Rhijn, 2002, Frequent FGFR3 mutations in urothelial papilloma, J Pathol, 198, 245, 10.1002/path.1202

Trudel S, Ely S, Farooqi Y, Affer M, Robbiani DF, Chesi M, et al. Inhibition of fibroblast growth factor receptor 3 induces differentiation and apoptosis in t(4;14) myeloma. Blood 2004;103(9):3521–8.

Reiter, 1998, Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome, Blood, 92, 1735, 10.1182/blood.V92.5.1735

Smedley, 1998, The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP, Hum Mol Genet, 7, 637, 10.1093/hmg/7.4.637

Popovici, 1998, Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13), Proc Natl Acad Sci USA, 95, 5712, 10.1073/pnas.95.10.5712

Xiao, 1998, FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome, Nat Genet, 18, 84, 10.1038/ng0198-84

Popovici, 1999, The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1, Blood, 93, 1381, 10.1182/blood.V93.4.1381

Guasch, 2000, FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33), Blood, 95, 1788, 10.1182/blood.V95.5.1788.005k15_1788_1796

Guasch, 2003, Endogenous retroviral sequence is fused to FGFR1 kinase in the 8p12 stem-cell myeloproliferative disorder with t(8;19)(p12;q13.3), Blood, 101, 286, 10.1182/blood-2002-02-0577

Heath, 2004, Critical role of STAT5 activation in transformation mediated by ZNF198–FGFR1, J Biol Chem, 279, 6666, 10.1074/jbc.M308743200

Demiroglu, 2001, The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins, Blood, 98, 3778, 10.1182/blood.V98.13.3778

Roumiantsev, 2004, Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198–FGFR1 and BCR–FGFR1 fusion genes from 8p11 translocations, Cancer Cell, 5, 287, 10.1016/S1535-6108(04)00053-4

Cortes, 2003, Efficacy of the farnesyl transferase inhibitor R115777 in chronic myeloid leukemia and other hematologic malignancies, Blood, 101, 1692, 10.1182/blood-2002-07-1973

Kurzrock, 2004, Phase II study of R115777, a farnesyl transferase inhibitor, in myelodysplastic syndrome, J Clin Oncol, 22, 1287, 10.1200/JCO.2004.08.082

Fioretos, 2001, Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL, Genes Chromosomes Cancer, 32, 302, 10.1002/gcc.1195